当前位置: 首页 > 期刊 > 《中国现代医生》 > 2021年第14期
编号:669982
益生菌联合美沙拉嗪对溃疡性结肠炎患者的效果分析及对NGAL、MUC2蛋白影响
http://www.100md.com 2021年7月14日 中国现代医生 2021年第14期
     霍惠子

    [關键词] 溃疡性结肠炎;美沙拉嗪;益生菌;炎症因子;肠道菌群;免疫功能

    [中图分类号] R574.2? ? ? ? ? [文献标识码] B? ? ? ? ? [文章编号] 1673-9701(2021)14-0111-04

    Effect analysis of probiotics combined with mesalazine on patients with ulcerative colitis and its effect on NGAL and MUC2 protein

    HUO Huizi

    Department of Pharmacy,the Central Hospital of Jiamusi City in Heilongjiang Province, Jiamusi? ?154002, China

    [Abstract] Objective To explore the clinical efficacy of probiotics combined with mesalazine on patients with ulcerative colitis and the effects on neutrophil gelatinase-related lipid carrier protein (NGAL) and intestinal mucin 2 (MUC2) levels. Methods A total of 98 patients with ulcerative colitis admitted to our hospital from June 2018 to June 2020 were collected as research objects. They were randomLy divided into the observation group and the control group, with 49 cases in each group. The control group was treated with mesalazine, while the observation group was treated with probiotics combined with mesalazine. The clinical efficacy, NGAL, MUC2, flora distribution, T lymphocyte subsets and the incidence of adverse reactions of the two groups of patients were recorded and compared. Results The total effective rate was 89.80% (44/49) in the observation group ......

您现在查看是摘要页,全文长 10538 字符